Industrial Sources Generate a Different PFAS Signature
Drinking water regulations and the filter certification standards built around them were developed primarily with municipal water supply protection in mind. The PFAS compound profiles found in industrial wastewater — from fluorochemical manufacturing facilities, electroplating operations, semiconductor fabs, textile finishing plants, paper and food packaging manufacturers, and AFFF-contaminated sites — differ substantially from those found in downstream municipal water supplies. Industrial wastewater may contain precursor compounds, novel PFAS, and short-chain compounds at concentrations and in relative abundances that are not reflected in drinking water monitoring data or in the compound lists used for certification testing.
This disconnect matters because industrial water users — facilities treating their own process water or discharge to municipal sewer systems — often evaluate treatment technologies using the same criteria and certifications developed for drinking water applications. A treatment system that meets NSF/ANSI 53 PFAS certification may be wholly inadequate for the compound profile in a specific industrial discharge stream.
Fluorochemical Manufacturing: The Source End of the Spectrum
Wastewater from fluorochemical manufacturing facilities contains the highest PFAS diversity of any industrial source category. Manufacturing processes generate a range of intermediates, byproducts, and off-specification products that span the PFAS structural spectrum from C3 to C14+, including branched isomers, precursor compounds, and novel PFAS not listed in regulatory compound panels. Electrochemical fluorination processes, in particular, generate complex isomeric mixtures that challenge both analytical characterization and treatment optimization.
Studies of manufacturing facility effluents using non-targeted mass spectrometric screening have routinely identified PFAS compounds not present in commercially available analytical standards — meaning they cannot be quantified by conventional targeted monitoring methods. These ‘unknown PFAS’ may represent a substantial fraction of the total organofluorine load in manufacturing discharge. Total oxidizable precursor (TOP) assays applied to manufacturing effluents consistently reveal precursor concentrations that far exceed terminal PFAS concentrations measured by targeted analysis.
AFFF-Impacted Sites: Legacy Compounds in Complex Matrices
Aqueous film-forming foam (AFFF) used at military bases, airports, and fire training facilities is the most widespread source of environmental PFAS contamination globally. AFFF formulations used through the 1990s and 2000s were complex mixtures containing hundreds of PFAS compounds, including PFOS and its ECF-derived isomers, PFOA and related PFCAs, fluorotelomer alcohols and sulfonic acids, and perfluoroalkyl sulfonamide compounds.
Groundwater beneath AFFF-impacted sites thus contains a mixture that reflects this formulation complexity: not just PFOA and PFOS, but the full array of co-contaminants, precursor compounds, and transformation products generated from AFFF degradation over decades of subsurface transport. Treatment systems deployed at AFFF-contaminated sites using GAC optimized for PFOA/PFOS removal frequently achieve compliance for those two compounds while allowing PFBS, fluorotelomer compounds, and other co-contaminants to pass through.
Industrial Treatment Standards vs. Drinking Water Standards
The appropriate framework for evaluating PFAS treatment in industrial applications is not NSF/ANSI 53 — which was designed for point-of-use drinking water treatment — but rather compound-specific characterization of the discharge stream, followed by technology evaluation against the actual compound profile present. This requires a broader analytical scope than standard 40-compound targeted PFAS panels, including non-targeted screening when novel or unknown compounds are suspected.
Industrial PFAS treatment design that begins with comprehensive compound characterization — including precursor identification via TOP assay, isomer resolution for legacy compounds, and non-targeted screening for manufacturing effluents — produces treatment systems that are sized and configured appropriately for the actual contaminant load rather than for the two-compound regulatory reference case. The cost of this more comprehensive characterization is modest relative to the cost of installing a treatment system that fails to meet discharge targets.